Mr. Michael A Tomeo

Mr. Michael A Tomeo (MR. MICHAEL A TOMEO ) is A Dermatology Physician in Doylestown, PA. The NPI Number for Mr. Michael A Tomeo is 1326046830.

The current location address for Mr. Michael A Tomeo is 610 FARM LANE Doylestown, PA 18901 and the contact number is 2153454736 and fax number is 2153454749. The mailing address for Mr. Michael A Tomeo is 610 FARM LANE Doylestown, PA 18901- 2153454736 (mailing address contact number - 2153454736).

A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.

What is the NPI Number for Mr. Michael A Tomeo ?

Answer: The NPI Number for Mr. Michael A Tomeo is 1326046830

Where is Mr. Michael A Tomeo located?

Answer: Mr. Michael A Tomeo is located at 610 FARM LANE Doylestown, PA 18901.

What is the specialty for Mr. Michael A Tomeo ?

Answer: The Specialty of Mr. Michael A Tomeo is A Dermatology Physician.

Are there any online reviews for Mr. Michael A Tomeo ?

Answer: Yes! Check It Now.

Are there any other health care providers in Doylestown, PA?

Answer: Yes, there are given below...

Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Mr. Michael A Tomeo

Number of HCPCS	28
Number of Medicare Beneficiaries	162
Number of Services	733
Total Submitted Charge Amount	81656
Total Medicare Allowed Amount	41803.8
Total Medicare Payment Amount	31662.69
Total Medicare Standardized Payment Amount	29111.52
Drug Suppress Indicator	*
Number of HCPCS Associated With Drug Services
Number of Medicare Beneficiaries With Drug Services
Number of Drug Services
Total Drug Submitted Charge Amount
Total Drug Medicare Allowed Amount
Total Drug Medicare Payment Amount
Total Drug Medicare Standardized Payment Amount
Medical Suppress Indicator	#
Number of HCPCS Associated With Medical Services
Number of Medicare Beneficiaries With Medical
Number of Medical Services
Total Medical Submitted Charge Amount
Total Medical Medicare Allowed Amount
Total Medical Medicare Payment Amount
Total Medical Medicare Standardized Payment Amount
Average Age of Beneficiaries	74
Number of Beneficiaries Age Less 65
Number of Beneficiaries Age 65 to 74	78
Number of Beneficiaries Age 75 to 84	59
Number of Beneficiaries Age Greater 84
Number of Female Beneficiaries	67
Number of Male Beneficiaries	95
Number of Non-Hispanic White Beneficiaries	149
Number of Black or African American Beneficiaries
Number of Asian Pacific Islander Beneficiaries
Number of Hispanic Beneficiaries
Number of American Indian/Alaska Native Beneficiaries	0
Number of Beneficiaries With Race Not Elsewhere Classified
Number of Beneficiaries With Medicare & Medicaid Entitlement
Number of Beneficiaries With Medicare Only Entitlement
Percent (%) of Beneficiaries Identified With Atrial Fibrillation	0.12
Percent (%) of Beneficiaries Identified With Alzheimer's Disease or Dementia
Percent (%) of Beneficiaries Identified With Asthma
Percent (%) of Beneficiaries Identified With Cancer	0.1
Percent (%) of Beneficiaries Identified With Heart Failure	0.15
Percent (%) of Beneficiaries Identified With Chronic Kidney Disease	0.21
Percent (%) of Beneficiaries Identified With Chronic Obstructive Pulmonary Disease	0.09
Percent (%) of Beneficiaries Identified With Depression	0.16
Percent (%) of Beneficiaries Identified With Diabetes	0.17
Percent (%) of Beneficiaries Identified With Hyperlipidemia	0.66
Percent (%) of Beneficiaries Identified With Hypertension	0.61
Percent (%) of Beneficiaries Identified With Ischemic Heart Disease	0.32
Percent (%) of Beneficiaries Identified With Osteoporosis	0.1
Percent (%) of Beneficiaries Identified With Rheumatoid Arthritis / Osteoarthritis	0.42
Percent (%) of Beneficiaries Identified With Schizophrenia / Other Psychotic Disorders	0
Percent (%) of Beneficiaries Identified With Stroke
Average HCC Risk Score of Beneficiaries	1.0165

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type	Dermatology
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills	114
Number of Standardized 30-Day Fills	120
Aggregate Cost Paid for All Claims	4185.89
Number of Day's Supply for All Claims	2665
Number of Medicare Beneficiaries	60
Number of Claims, Including Refills, for Beneficiaries Age 65+
Including Refills, for Beneficiaries Age 65+
Beneficiaries Age 65+
Number of Day's Supply for All Claims for Beneficaries Age 65+
Number of Medicare Beneficiaries Age 65+
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst	*
Total Claims of Brand-Name Drugs
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills	105
Aggregate Cost Paid for Generic Drugs	3443.36
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst	#
Total Claims of Other Drugs, Including Refills
Aggregate Cost Paid for Other Drugs
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans	49
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans	1943.93
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans	65
Aggregate Cost Paid for Claims Filled by	2241.96
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst
Number of Claims for Beneficiaries Covered by Low-Income Subsidy	12
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy	560.53
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy	102
by Low-Income Subsidy	3625.36
Total Claims of Opioid Drugs, Including
Aggregate Cost Paid for Opioid Drugs
Opioid Claims
Opioid_Tot_Clms divided by the Tot_Clms
Total Claims of Long-Acting Opioid Drugs
Aggregate Cost Paid for Long-Acting Opioid
Number of Day's Supply of All Long-Acting
Long-Acting Opioid Claims
Opioid_LA_Tot_Clms divided by the
Total Claims of Antibiotic Drugs, Including
Aggregate Cost Paid for Antibiotic Drugs
Antibiotic Claims
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst	*
Including Refills, for Beneficiaries Age 65+
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims
Average Age of Beneficiaries	76.35
Number of Beneficiaries Age Less Than 65
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries	23
Number of Male Beneficiaries	37
Number of Non-Hispanic White	53
Number of Black or African American
Number of Asian Pacific Islander
Number of Hispanic Beneficiaries
Number of American Indian/Alaskan NativeBeneficiaries	0
Number of Beneficiaries with Race Not
Only Entitlement
Average Hierarchical Condition Category	1.31535